Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: December 2010

Chapter 16 - Episodic ataxias

Summary

Paroxysmal dyskinesias are a heterogeneous group of disorders characterized by intermittent attacks of hyperkinetic involuntary movements without loss of consciousness. The paroxysmal movements may affect the arm or leg on one or both sides of the body, or all extremities. All kinds of paroxysmal dyskinesias may be symptomatic in origin. Twenty-two percent of one series of patients with paroxysmal movement disorders had underlying causative diseases. History and neurologic examination are the cornerstones on the way to the diagnosis of paroxysmal dyskinesias. The paroxysmal nature and predominantly short duration of the attacks, the aura symptoms and the response to even low doses of anticonvulsant drugs suggest that paroxysmal dyskinesias closely resemble epilepsy. Sandifer syndrome is a rare movement disorder in toddlers. During or immediately after feeding, affected children exhibit severe dystonic movements or postures of the head and neck. They often vomit and are malnourished.

Related content

Powered by UNSILO

References

AdelmanJP, BondCT, PessiaM, MaylieJ. Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 1995 Dec, 15(6):1449–1454.
AuburgerG, RatzlaffT, LunkesA, NellesHW, LeubeB, BinkofskiF, KugelH, HeindelW, SeitzR, BeneckeR, WitteOW, VoitT. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 1996 Jan 1, 31(1):90–94.
BalohRW, YueQ, FurmanJM, NelsonSF. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 1997 Jan, 41(1):8–16.
BrandtT, StruppM. Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo). Review. Audiol Neurootol 1997 Nov-Dec, 2(6):373–383.
BretschneiderF, WrischA, Lehmann-HornF, GrissmerS. Expression in mammalian cells and electrophysiological characterization of two mutant Kv1.1 channels causing episodic ataxia type 1 (EA-1). Eur J Neurosci 1999 Jul, 11(7):2403–2412.
BrowneDL, GancherST, NuttJG, BruntER, SmithEA, KramerP, LittM. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994 Oct, 8(2):136–140.
BrowneDL, BruntER, GriggsRC, NuttJG, GancherST, SmithEA, LittM. Identification of two new KCNA1 mutations in episodic ataxia/myokymia families. Hum Mol Genet 1995 Sep, 4(9):1671–1672.
BruntER, van WeerdenTW. Familial paroxysmal kinesigenic ataxia and continuous myokymia. Brain 1990 Oct, 113 (Pt 5):1361–1382.
CaderMZ, SteckleyJL, DymentDA, McLachlanRS, EbersGC. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology 2005 Jul 12, 65(1):156–158.
CraigK, ElliottHR, KeersSM, LambertC, PyleA, GravesTD, WoodwardC, SweeneyMG, DavisMB, HannaMG, ChinneryPF. Episodic ataxia and hemiplegia caused by the 8993T->C mitochondrial DNA mutation. J Med Genet 2007 Dec, 44(12):797–799.
D’AdamoMC, LiuZ, AdelmanJP, MaylieJ, PessiaM. Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel. EMBO J 1998 Mar 2, 17(5):1200–1207.
DamjiKF, AllinghamRR, PollockSC, SmallK, LewisKE, StajichJM, YamaokaLH, VanceJM, Pericak-VanceMA. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Review. Arch Neurol 1996 Apr, 53(4):338–344.
DenierC, DucrosA, DurrA, EymardB, ChassandeB, Tournier-LasserveE. Missense CACNA1A mutation causing episodic ataxia type 2. Arch Neurol 2001 Feb, 58(2):292–295.
DucrosA, DenierC, JoutelA, CecillonM, LescoatC, VahediK, DarcelF, VicautE, BousserMG, Tournier-LasserveE. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001 Jul 5, 345(1):17–24.
EscaygA, De WaardM, LeeDD, BichetD, WolfP, MayerT, JohnstonJ, BalohR, SanderT, MeislerMH. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000 May, 66(5):1531–1539. Epub 2000 Apr 4.
EtzionY, GrossmanY. Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 2001 Aug, 139(4):419–425.
EunsonLH, ReaR, ZuberiSM, YouroukosS, PanayiotopoulosCP, LiguoriR, AvoniP, McWilliamRC, StephensonJB, HannaMG, KullmannDM, SpauschusA. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 2000 Oct, 48(4):647–656.
FarmerTW, MustianVM. Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations. Arch Neurol 1963 May, 8:471–480.
FletcherCF, LutzCM, O’SullivanTN, ShaughnessyJD, HawkesR, FrankelWN, CopelandNG, JenkinsNA. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996 Nov 15, 87(4):607–617.
FuremanBE, HessEJ. Noradrenergic blockade prevents attacks in a model of episodic dysfunction caused by a channelopathy. Neurobiol Dis 2005 Nov, 20(2):227–232.
FuremanBE, JinnahHA, HessEJ. Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering. Pharmacol Biochem Behav 2002 Oct, 73(3):631–637.
GriggsRC, MoxleyRT, LafranceRA, McQuillenJ. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 1978 Dec, 28(12):1259–1264.
GuidaS, TrettelF, PagnuttiS, MantuanoE, TotteneA, VenezianoL, FellinT, SpadaroM, StaudermanK, WilliamsM, VolsenS, OphoffR, FrantsR, JodiceC, FrontaliM, PietrobonD. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet 2001 Mar, 68(3):759–764.
HarnoH, HeikkinenS, KaunistoMA, KallelaM, HäkkinenAM, WessmanM, FärkkiläM, LundbomN. Decreased cerebellar total creatine in episodic ataxia type 2: a 1H MRS study. Neurology 2005 Feb 8, 64(3):542–544.
HersonPS, VirkM, RustayNR, BondCT, CrabbeJC, AdelmanJP, MaylieJ. A mouse model of episodic ataxia type-1. Nat Neurosci 2003 Apr, 6(4):378–383.
HoltmannM, OppJ, TokarzewskiM, Korn-MerkerE. Human epilepsy, episodic ataxia type 2, and migraine. Lancet 2002 Jan 12, 359(9301):170–171.
ImbriciP, JaffeSL, EunsonLH, DaviesNP, HerdC, RobertsonR, KullmannDM, HannaMG. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 2004 Dec, 127(Pt 12):2682–2692.
ImbriciP, EunsonLH, GravesTD, BhatiaKP, WadiaNH, KullmannDM, HannaMG. Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology 2005 Sep 27, 65(6):944–946.
JenJ, WanJ, GravesM, YuH, MockAF, CoulinCJ, KimG, YueQ, PapazianDM, BalohRW. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 2001 Nov 27, 57(10):1843–1848.
JenJ, KimGW, BalohRW. Clinical spectrum of episodic ataxia type 2. Neurology 2004 Jan 13, 62(1):17–22.
JenJC, WanJ, PalosTP, HowardBD, BalohRW. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia and seizures. Neurology 2005 Aug 23, 65(4):529–534.
JengCJ, ChenYT, ChenYW, TangCY. Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2. Am J Physiol Cell Physiol 2006 Apr, 290(4):C1209–C1220.
JengCJ, SunMC, ChenYW, TangCY. Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca2+ channels. J Cell Physiol 2008 Feb, 214(2):422–433.
JodiceC, MantuanoE, VenezianoL, TrettelF, SabbadiniG, CalandrielloL, FranciaA, SpadaroM, PierelliF, SalviF, Ophoff RQA, FrantsRR, FrontaliM. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 1997 Oct, 6(11):1973–1978.
JouvenceauA, EunsonLH, SpauschusA, RameshV, ZuberiSM, KullmannDM, HannaMG. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 2001 Sep 8, 358(9284):801–807.
JulienJ, DenierC, FerrerX, DucrosA, SaintaraillesJ, LaguenyA, Tournier-LasserveE, VitalC. Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease?J Neurol 2001 Mar, 248(3):209–214.
KinaliM, JungbluthH, EunsonLH, SewryCA, ManzurAY, MercuriE, HannaMG, MuntoniF. Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia. Neuromuscul Disord 2004 Oct, 14(10):689–693.
KramerPL, YueQ, GancherST, NuttJG, BalohR, SmithE, BrowneD, BusseyK, LovrienE, NelsonS et al. A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p. Am J Hum Genet 1995 Jul, 57(1):182–185.
LeeH, WangH, JenJC, SabattiC, BalohRW, NelsonSF. A novel mutation in KCNA1 causes episodic ataxia without myokymia. Hum Mutat 2004 Dec, 24(6):536.
LeeHY, XuY, HuangY, AhnAH, AuburgerGW, PandolfoM, KwiecinskiH, GrimesDA, LangAE, NielsenJE, AveryanovY, ServideiS, FriedmanA, Van BogaertP, AbramowiczMJ, BrunoMK, SorensenBF, TangL, FuYH, PtácekLJ. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004 Dec 15, 13(24):3161–3170.
LittM, KramerP, BrowneD, GancherS, BruntER, RootD, PhromchotikulT, DubayCJ, NuttJ. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am J Hum Genet 1994 Oct, 55(4):702–709.
ManganasLN, AkhtarS, AntonucciDE, CampomanesCR, DollyJO, TrimmerJS. Episodic ataxia type-1 mutations in the Kv1.1 potassium channel display distinct folding and intracellular trafficking properties. J Biol Chem 2001 Dec 28, 276(52):49427–49434.
MaselliRA, WanJ, DunneV, GravesM, BalohRW, WollmannRL, JenJ. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology 2003 Dec 23, 61(12):1743–1748.
MochizukiY, KawataA, MizutaniT, TakamotoK, HayashiH, TakiK, MorimatsuY. Hereditary paroxysmal ataxia with mental retardation: a clinicopathological study in relation to episodic ataxia type 2. Acta Neuropathol 2004 Oct, 108(4):345–349.
MoriY, WakamoriM, OdaS, FletcherCF, SekiguchiN, MoriE, CopelandNG, JenkinsNA, MatsushitaK, MatsuyamaZ, ImotoK. Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol)). J Neurosci 2000 Aug 1, 20(15):5654–5662.
OphoffRA, TerwindtGM, VergouweMN, van EijkR, OefnerPJ, HoffmanSM, LamerdinJE, MohrenweiserHW, BulmanDE, FerrariM, HaanJ, LindhoutD, van OmmenGJ, HofkerMH, FerrariMD, FrantsRR. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996 Nov 1, 87(3):543–552.
PoujoisA, AntoineJC, CombesA, TouraineRL. Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 gene. J Neurol 2006 Jul, 253(7):957–959.
ReaR, SpauschusA, EunsonLH, KullmannDM. Variable K(+) channel subunit dysfunction in inherited mutations of KCNA1. J Physiol 2002 Jan 1, 538(Pt 1):5–23.
RuckerJC, JenJ, StahlJS, NatesanN, BalohRW, LeighRJ. Internuclear ophthalmoparesis in episodic ataxia type 2. Ann NY Acad Sci 2005 Apr, 1039:571–574.
Sappey-MarinierD, VighettoA, PeyronR, BroussolleE, BonmartinA. Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol 1999 Aug, 46(2):256–259.
SasakiO, JenJC, BalohRW, KimGW, IsawaM, UsamiS. Neurotological findings in a family with episodic ataxia. J Neurol 2003 Mar, 250(3):373–375.
ScogganKA, FriedmanJH, BulmanDE. CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. Can J Neurol Sci 2006 Feb, 33(1):68–72.
ShookSJ, MamsaH, JenJC, BalohRW, ZhouL. Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea. Muscle Nerve 2007 Oct 2.
SmartSL, LopantsevV, ZhangCL, RobbinsCA, WangH, ChiuSY, SchwartzkroinPA, MessingA, TempelBL. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998 Apr, 20(4):809–819.
SpaceySD, MaterekLA, SzczygielskiBI, BirdTD. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol 2005 Feb, 62(2):314–316.
SteckleyJL, EbersGC, CaderMZ, McLachlanRS. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology 2001 Oct 23, 57(8):1499–1502.
StruppM, SchülerO, KrafczykS, JahnK, SchautzerF, BüttnerU, BrandtT. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 2003 Jul 22, 61(2):165–170.
TomitaH, NagamitsuS, WakuiK, FukushimaY, YamadaK, SadamatsuM, MasuiA, KonishiT, MatsuishiT, AiharaM, ShimizuK, HashimotoK, MinetaM, MatsushimaM, TsujitaT, SaitoM, TanakaH, TsujiS, TakagiT, NakamuraY, NankoS, KatoN, NakaneY, NiikawaN. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am J Hum Genet 1999 Dec, 65(6):1688–1697.
TotteneA, FellinT, PagnuttiS, LuvisettoS, StriessnigJ, FletcherC, PietrobonD. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci USA 2002 Oct 1, 99(20):13284–13289.
Van BogaertP, SzliwowskiHB. EEG findings in acetazolamide-responsive hereditary paroxysmal ataxia. Neurophysiol Clin 1996, 26(5):335–340.
VanceJM, Pericak-VanceMA, PayneCS, CoinJT, OlanowCW. Linkage and genetic analysis in adult onset periodic vestibulo-cerebellar ataxia: report of a new family (Abstract). Am J Hum Genet 36:78S, 1984.
VighettoA, FromentJC, TrilletM, AimardG. Magnetic resonance imaging in familial paroxysmal ataxia. Arch Neurol 1988 May, 45(5):547–549.
WakamoriM, YamazakiK, MatsunodairaH, TeramotoT, TanakaI, NiidomeT, SawadaK, NishizawaY, SekiguchiN, MoriE, MoriY, ImotoK. Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel. J Biol Chem 1998 Dec 25, 273(52):34857–34867.
WalterJT, AlviñaK, WomackMD, ChevezC, KhodakhahK . Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci 2006 Mar, 9(3):389–397.
WapplE, KoschakA, PoteserM, SinneggerMJ, WalterD, EberhartA, GroschnerK, GlossmannH, KrausRL, GrabnerM, StriessnigJ. Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J Biol Chem 2002 Mar 1, 277(9):6960–6966.
WeiszCJ, RaikeRS, Soria-JassoLE, HessEJ . Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering. J Neurosci 2005 Apr 20, 25(16):4141–4145.
ZasorinNL, BalohRW, MyersLB. Acetazolamide-responsive episodic ataxia syndrome. Neurology 1983 Sep, 33(9):1212–1214.
ZerrP, AdelmanJP, MaylieJ. Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency. J Neurosci 1998 Apr 15, 18(8):2842–2848.
ZhangCL, MessingA, ChiuSY. Specific alteration of spontaneous GABAergic inhibition in cerebellar purkinje cells in mice lacking the potassium channel Kv1. 1. J Neurosci 1999 Apr 15, 19(8):2852–2864.
ZhuchenkoO, BaileyJ, BonnenP, AshizawaT, StocktonDW, AmosC, DobynsWB, SubramonySH, ZoghbiHY, LeeCC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997 Jan, 15(1):62–69.
ZuberiSM, EunsonLH, SpauschusA, De SilvaR, TolmieJ, WoodNW, McWilliamRC, StephensonJB, KullmannDM, HannaMG. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 1999 May, 122 (Pt 5):817–825.